Assessment of Distal Radius Bone Mineral Density in Osteoporosis Patients Receiving Denosumab, Including Those with Rheumatoid Arthritis and Those Receiving Oral Glucocorticoids

BACKGROUND AND OBJECTIVES: Recently, the osteoporosis treatment has attracted attention, and several drugs have been developed. Among these, bisphosphonates (BPs), parathyroid hormone (PTH) and anti-receptor activator of nuclear factor kappa B ligand (RANKL) monoclonal (MAb) denosumab (DMAb) are the...

Descripción completa

Detalles Bibliográficos
Autor principal: Matsuno, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114204/
https://www.ncbi.nlm.nih.gov/pubmed/27766589
http://dx.doi.org/10.1007/s40268-016-0146-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114204/
https://www.ncbi.nlm.nih.gov/pubmed/27766589
http://dx.doi.org/10.1007/s40268-016-0146-8

Ejemplares similares